{
    "2019-11-06": [
        [
            {
                "time": "",
                "original_text": "【西部医药吴文华】大参林深度报告：省内精耕省外加速，盈利进入良性循环",
                "features": {
                    "keywords": [
                        "大参林",
                        "省内精耕",
                        "省外加速",
                        "盈利",
                        "良性循环"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "大参林：拟1.27亿元收购南通江海大药房51%股权",
                "features": {
                    "keywords": [
                        "大参林",
                        "收购",
                        "南通江海大药房",
                        "股权"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大参林(603233.SH)拟1.27亿元收购南通江海大药房51%的股权",
                "features": {
                    "keywords": [
                        "大参林",
                        "603233.SH",
                        "收购",
                        "南通江海大药房",
                        "股权"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}